Pathological Characteristics of Aspirated Thrombi From Coronary Artery Embolism in Patients With Acute Myocardial Infarction

Takao Konishi,Naohiro Funayama,Daisuke Sunaga,K. Ohori,Tadashi Yamamoto,Yusuke Kashiwagi,D. Hotta,Kenji Yamazaki,Hiroshi Nishihara,Shinya Tanaka

Published 2025 in Cureus

ABSTRACT

Background: The pathological differences in aspirated thrombi between atherosclerotic causes and coronary artery embolism (CE) in patients with acute myocardial infarction (AMI) remain poorly understood. The purpose of this study was to compare the pathological features of aspirated thrombi between AMI patients with CE and those with atherosclerotic causes (non-CE). Methods: We analyzed coronary thrombi retrieved between 2015 and 2019 from 89 consecutive patients presenting with de novo AMI, of whom four had CE and 85 did not. CE was diagnosed based on angiographic and other diagnostic imaging findings. The samples were stained with hematoxylin and eosin (H&E) and elastica-Masson stain (EM). Immunohistochemistry was performed using specific antibodies against CD34 and CD68 to detect endothelial cells and macrophages, respectively. The aspirated thrombi were assessed for their histopathological characteristics. Results: Atrial fibrillation (AF) was more frequently documented in patients with CE than in those with non-CE (100% vs. 9%). The erythrocytes and erythrocytes/total thrombus areas were greater. The prevalence of erythrocyte-dominant thrombi was significantly higher in patients with CE than in those with non-CE (4.94 mm² (3.38-7.35 mm²) vs. 0.62 mm² (0.05-2.51 mm²); 55.6% (50.9-57.7%) vs. 12.6% (2.0-36.2%), P = 0.002; and 75% vs. 7%, P = 0.003, respectively). The age of aspirated thrombi was significantly fresher in CE than in the non-CE (“fresh”: 75% vs. 18%, “lytic”: 25% vs. 28%, and “old”: 0% vs. 54%, respectively). Conclusions: This study suggests that aspirated thrombi derived from patients with AMI due to CE are more erythrocyte-dominant and fresher than those derived from patients with AMI due to atherosclerotic causes. Identifying the etiology of patients with AMI is important because anticoagulation therapy is essential for secondary prevention in patients with CE.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-30 of 30 references · Page 1 of 1

CITED BY

  • No citing papers are available for this paper.

Showing 0-0 of 0 citing papers · Page 1 of 1